74 related articles for article (PubMed ID: 16644774)
1. Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible?
Grootscholten C; Berden JH
Nephrol Dial Transplant; 2006 Jun; 21(6):1465-9. PubMed ID: 16644774
[No Abstract] [Full Text] [Related]
2. [Recommendations for the treatment of lupus nephritis].
Djukanović L; Bogdanović R; Jovanović D; Mitić B; Mitić I; Petrović R; Rasković S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():50-4. PubMed ID: 12583314
[No Abstract] [Full Text] [Related]
3. [Immune intervention therapy of lupus nephritis must be individualized and standardized].
Yin PD
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):940-1. PubMed ID: 16060996
[No Abstract] [Full Text] [Related]
4. Beyond immunosuppression - challenges in the clinical management of lupus nephritis.
Masood S; Jayne D; Karim Y
Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111
[TBL] [Abstract][Full Text] [Related]
5. Multitarget therapy of lupus nephritis: base hit or home run?
Glassock RJ
J Am Soc Nephrol; 2008 Oct; 19(10):1842-4. PubMed ID: 18753251
[No Abstract] [Full Text] [Related]
6. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
7. Lupus nephritis.
Sauter M; Anders HJ
Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for resistant lupus nephritis.
Mok CC
Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
[TBL] [Abstract][Full Text] [Related]
10. Treatment of proliferative lupus nephritis--a critical approach.
Buhaescu I; Covic A; Deray G
Semin Arthritis Rheum; 2007 Feb; 36(4):224-37. PubMed ID: 17067659
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
Moroni G; Doria A; Ponticelli C
Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
[No Abstract] [Full Text] [Related]
12. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
Boumpas DT; Sidiropoulos P; Bertsias G
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
[TBL] [Abstract][Full Text] [Related]
13. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis.
Chan TM
Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038
[No Abstract] [Full Text] [Related]
14. Treatment of membranous lupus nephritis: where are we now?
Beck LH; Salant DJ
J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
[No Abstract] [Full Text] [Related]
15. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK
Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine, the Cinderella in the treatment of lupus nephritis.
Berden JH
Nephrol Dial Transplant; 2009 Aug; 24(8):2611-2; author reply 2612. PubMed ID: 19509027
[No Abstract] [Full Text] [Related]
17. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
[TBL] [Abstract][Full Text] [Related]
18. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
Jedlickova H; Bohmová J; Sirotkova A
Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
[No Abstract] [Full Text] [Related]
19. [Lupus nephritis in Senegal: study of 42 cases].
Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
